Contract germ-free and microbiome mouse studies (Emory Gnotobiotic Animal Core)

Facilities & testing
University

Emory's gnotobiotic mouse core runs mouse studies on contract in its SPF facility, supplies GSF/ASF animals and germ-free housing at published external rates, and can provide human microbiome-associated mice for academic and industry clients who want to outsource in vivo microbiome work.

Overview

The Emory Gnotobiotic Animal Core (EGAC), part of Emory Integrated Core Facilities, lets investigators experimentally manipulate the microbiomes of mice in a controlled environment. The core provides contract research organization (CRO) services to academic researchers at other universities and to industry partners that prefer to outsource in vivo work.

Available services
  • Full execution of mouse studies in a specific pathogen-free (SPF) facility, including dosing of therapeutics and longitudinal sample collection
  • Supply of GSF/ASF animals, and germ-free housing in experimental isolators and isocages
  • Human microbiome-associated (HMA) mice: germ-free mice colonized with human fecal samples, for testing drugs, dietary components, probiotics and microbiota-targeted therapies
  • Fecal pellet, colon tissue and small intestine tissue collection
  • Isolator testing, technical services, study design guidance and data documentation
Equipment & instruments
  • Parkbio rigid isolators, each housing 16 mouse cages
  • Tecniplast ISOcage P Bioexclusion system of airtight, positive-pressure individual cages for germ-free, gnotobiotic and bioexclusion studies
Access & engagement

All listed services are available at published external rates, covering animals, samples, housing and project set-up fees. Clients start by contacting the core for a quote and a user agreement.


About Emory University

Emory University is a comprehensive private research university in Atlanta, anchored by a major academic health center and a mid-sized, research-active faculty. Integration with its academic health system provides direct access to patients, clinicians, and real-world data, enabling rapid clinical translation and large, multisite trials. A hospital-embedded innovation hub and proximity to the CDC and Atlanta’s corporate ecosystem create frequent pathways for co-development, testing, and deployment with industry partners; a long-standing partnership with a neighboring engineering powerhouse broadens prototyping and scale-up options. Research is supported by competitive federal funding, including the National Institutes of Health and the National Science Foundation. A dedicated technology transfer office supports IP strategy, licensing, startup formation, and streamlined industry agreements.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.